Navigation Links
Corneal Crouch Protector

ProductsCorneal Crouch Protector
Company Bausch & Lomb Storz
Item Corneal Crouch Protector
Features 
Description Developed for oculoplastic procedures for corneal and scleral protection. Dimensions enable protector to rest on the sclera and not on the cornea. Easily removed with Bishop-Harmon Forceps. Individually package sterile, 10 per box.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000
Web site: http://www.storz.com/

Related medicine products :

1. Castroviejo Corneal Trephine Set
2. Machat Corneal Spatula
3. Storz Corneal Burr
4. Handle for Corneal Burrs
5. Pediatric Corneal Shields 10/Box
6. Welch Allyn PanOptic Ophthalmoscope with Cobalt-Blue Filter and Corneal Viewing Lens
7. Catalano Corneal Scleral Forceps - 0.12 mm
8. Katzin-Barraquer Corneal Utility Forceps, Colibri Style
9. Harms Corneal Utility Forceps, Colibri Style
10. Storz Corneal Forceps, Colibri Style
11. Troutman-Barraquer Corneal Utility Forceps, Colibri Style
The LCS complete knee offers grit-blast textured components for cemented implantation and POROCOAT Porous Coated patellar, femoral and tibial components for cementless fixation.
...ak system includes a cruciate sparing version whic...th both resurfacing and inset patellas. Precision ...atics and fit with tibial articular surface and pa...ocations provide easy intraoperative change of siz...
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.
Advance Posterior Stabilized Total Knee systems improves patellofemoral kinematics, reduces wear rate potential, increases resistance to posterior tibial dislocation, achieves at least 120o flexion i
Medicine Products:
(Date:8/29/2008)...SNewswire/ -- The following is a,statement by Matt... Kids:, For the second time in a month, Philip Mo... and promotion of a concert in a developing countr...ngaging in cigarette,marketing that appeals to chi...s been forced to withdraw from,an August 30 reunio...
(Date:8/29/2008)... change that raises odds for malignancy, study fin...-- Some Japanese survivors of the World War II ato...ced key genetic changes that may have sparked the ...dicates. , Papillary thyroid cancer (PTC) is ty...volving the so-called BRAF gene. But Japanese rese...
(Date:8/29/2008)...wire-FirstCall/ -- InterMune, Inc.,(Nasdaq: ITMN ...CEO and,President of InterMune, will present at th...Boston on September 4, 2008 at 10:55 a.m. EDT., T... investors and other,interested parties may log on...porate website at http://www.intermune.com . The ...
(Date:8/29/2008)...re-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announ...egular,quarterly cash dividend of $0.50 per share ...d will be paid on October 3, 2008, to shareholders..., Landauer is the leading provider of analytical ...al radiation exposure. For more than 50 years,the...
Breaking Medicine News(10 mins):Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3
...nstein Institute for Medical Research have identif...s to determine the fertility of a man. Dr. Yous...ge migration inhibitory factor (MIF) is the key to...which is necessary for its union with an egg. Th...
...night outside Apple electronics stores in US citie...ed as the coolest gadget on the planet, when they ... puts a phone, web browser and music player in the... on sale at 6 p.m. (2200 GMT) Friday. Late Thursd...
....P.J. Abdul Kalam Friday called for taking advanta...stic tool and of tele-radiology to help the needy ... speaking during a visit to the digital radiology ... India Limited (ECIL), which is working towards pr...
...otection of the Child (SPARC) has said that Pakist...ate in South Asia. In a report prepared by it, SP...ork to assist their families. About 6.463 million... school, which is the second largest number of suc...
Other Medicine News:Health News:Tech Heads Go Gaga Waiting for Apple's IPhone 2
(Date:8/26/2008)...alif., Aug. 26 /- XTENT, In...ive one-year follow-up data,from the CUSTOM II tri...eer-reviewed journal, EuroIntervention. The lead a...., of University Medical Center Utrecht, Utrecht,...gators from 13 clinical,sites across Europe., The...
(Date:8/25/2008)...LS, Mass., Aug. 25 /- Joseph F. Finn,...pherics, Inc. ("Spherics") for,the benefit of cred...ellectual property will be sold at a sealed bid au...d release formulation of Levodopa-Carbidopa that,i...n,s disease, with global,sales estimated at approx...
(Date:8/22/2008)...any, August 22 /-, - Dangerous Bacte...ar, Sometimes something well-tried can also be in...nsidered to be very antimicrobial. This,ability is...inst dangerous,hospital germs. In a worldwide note...os Clinic in Wandsbek in Hamburg, Germany, was equ...
(Date:8/21/2008)...(R) assay shows clinical potential in independent ...t patients, COLUMBIA, Md., Aug. 21 /...et al.* in Clinical Transplantation has expanded o...toring cell-mediated,immunity in adult patients at...to kidney transplantation., Pablo Sanchez-Velasco...
Breaking Medicine Technology:XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 2New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation 3UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC 469 1UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC 469 2Hebrew SeniorLife researchers search for aging osteoporosis genes 467 1Hebrew SeniorLife researchers search for aging osteoporosis genes 467 2MITEM Releases Blue Iris eLaborate 8 6 1660 1MITEM Releases Blue Iris eLaborate 8 6 1660 2Audio 3A New Survey Finds Strong Public Interest in Prescription Drug Safety Issues 1656 1Audio 3A New Survey Finds Strong Public Interest in Prescription Drug Safety Issues 1656 2Audio 3A New Survey Finds Strong Public Interest in Prescription Drug Safety Issues 1656 3Audio 3A New Survey Finds Strong Public Interest in Prescription Drug Safety Issues 1656 4
... Maintained for at Least 24 Weeks, According,to Re...May 15, 2007 /PRNewswire/ -- Researchers from Guy,...icine have,announced the results from the first ra...valuating botulinum toxin type A (BTX-A,BOTOX(R))...ty (IDO),in patients with symptoms of overactive b...
...S WIRE)--May 17, 2007 - Pro-Pharmaceuticals,Inc. ...carbohydrate,compounds today announced that Elieze...Development and Manufacturing will present,"Pharm...umors of,5-FU with an Admixture of a Galactomannan...developmental Biology and Medicine,(ISOBM) Confere...
Other Medicine Technology:First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 2First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 3First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A),Significantly Improves Idiopathic Detrusor Overactivity (IDO) in,Patients With Symptoms of Overactive Bladder 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 2Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 3Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 4Pro-Pharmaceuticals to Present Abstract at the International,Society of Oncodevelopmental Biology and Medicine Conference 5